J. Lecomte
Institut Jules Bordet · 98 works · 1,003 citations · h-index 18
Top works
- Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
- Prognostic factors for patients with small cell lung carcinoma
- Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy
- Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
- A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
- Quelques aspects de l'étude électrophysiologique des réceppteurs sensoiriels des antennes d'Hyménoptères
- A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer
- Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
- A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer
- Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)
- A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer
- A phase III randomised study of concomitant induction radiochemotherapy testing two modalities of radiosensitisation by cisplatin (standard versus daily) for limited small-cell lung cancer
- A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer
- A phase II randomised trial comparing the cisplatin–etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer
- Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
- A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC)
- OBSERVATIONS SUR LE COMPORTEMENT DES ABEILLES BUTINEUSES
- Corrélation entre les tests cutanés et les tests de provocation bronchique chez l’asthmatique
- A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
- A phase III randomised study comparing two differentdose-intensity regimens as induction chemotherapy followedby thoracic irradiation in patients with advanced locoregionalnon-small-cell lung cancer